IMPACT Medicom

The Opioid Epidemic in Canada: What Can We Do?

October 22, 2020
IMPACT Medicom
The Opioid Epidemic in Canada: What Can We Do?
Show Notes

In this episode, we discuss the opioid epidemic in Canada and the use of naloxone, a life-saving drug that is used to prevent death from opioid overdose, with pharmacists: Dr. Ross Tsuyuki and Mark Barnes. 

  • Dr. Ross Tsuyuki - professor and chair of the Department of Pharmacology in the Faculty of Medicine and Dentistry at the University of Alberta.
  • Mark Barnes  - owner of Respect Rx  Pharmacies in Ottawa.


Our episode includes a discussion of:

  • The extent of the opioid epidemic in Canada and how COVID-19 has impacted the number of opioid-related deaths.
  • The use of the drug, naloxone, to prevent death from respiratory depression caused by opioid overdose. Naloxone is distributed as a nasal spray or injection kit and is supplied by pharmacists. 
  • The unique role of pharmacists in the distribution of naloxone  for the fight against the opioid epidemic. 
  • Who should be given a naloxone kit and its relevance in general for anyone prescribed opioids. 
  • The development of the first published guidelines for Canadian pharmacists on prescribing naloxone. The guidelines  can be found here: https://journals.sagepub.com/doi/pdf/10.1177/1715163520949973


**If you enjoy our podcast, please take the time to rate our podcast and subscribe**

For more great podcasts and other features, visit our website at: www.impactmedicom.com